Allergan (AGN) Comments on Recent Market Speculation; Still Sees Valeant (VRX) Offer as 'Grossly Inadequate'
Tweet Send to a Friend
The Board of Directors of Allergan, Inc. (NYSE: AGN) issued the following statement:There has recently been significant and potentially distracting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
